ArticleJournal of thoracic disease2018

EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma.

Hui Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.